WGSWW
GeneDx Holdings Corp.NASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
1.91
52W High
$0.13
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-17.60%
Forward P/E
—
PEG Ratio
—
About GeneDx Holdings Corp.
GeneDx Holdings Corp. (Ticker: WGSWW) is at the forefront of the genomics sector, specializing in genomic testing and precision medicine aimed at diagnosing rare and complex genetic disorders. Utilizing advanced sequencing technologies and an extensive genetic knowledge repository, GeneDx provides healthcare professionals with essential diagnostic resources that facilitate tailored treatment strategies. The company's diverse genetic testing portfolio, combined with strategic partnerships in the healthcare space, enhances its competitive positioning and underscores its commitment to revolutionizing personalized medicine while striving to improve patient outcomes through cutting-edge genetic healthcare solutions.
Fundamentals
| Revenue (TTM) | $442.68M |
| Gross Profit (TTM) | $307.91M |
| EBITDA | $-7.85M |
| Operating Margin | -25.60% |
| Return on Equity | -30.40% |
| Return on Assets | -4.37% |
| Revenue/Share (TTM) | $15.30 |
| Book Value | $8.57 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 17.40% |
| Shares Outstanding | 0 |
| Float | $18.94M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026